Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCH for thumb and first web space Dupuytren's contracture
NL-OMON37768Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2012
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by University Medical Center Groningen. Primary endpoint: Reduction in extension deficit to 0-5 degrees 30 days after last injection. Started Sep 2012; status: active, not recruiting.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on NL-OMON37768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37768.